Francesco Zinno

Francesco Zinno

Auto-generated profile, based on publicly available information

Francesco Zinno

Immunohematology Section, Annunziata Hospital, Cosenza, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2010 in Blood
Verified
Journal Article
Closed access
PDF file
PSPietro Sodani
Pietro Sodani
AIAntonella Isgrò
Antonella Isgrò
JGJavid Gaziev
Javid Gaziev
PPPaola Polchi
Paola Polchi
KPKatia Paciaroni
Katia Paciaroni
GLGuido Lucarelli
Guido Lucarelli
Fetomaternal microchimerism suggests immunological tolerance between mother and fetus. Thus, we performed primary hematopoietic stem cell transplantation from a mismatched mother to thalassemic patient without an human leukocyte antigen–identical donor. Twenty-two patients with thalassemia major were conditioned with 60 mg/kg hydroxyurea and 3 mg/kg azathioprine from day −59 to −11; 30 mg/m2 fludarabine from day −17 to −11; 14 mg/kg busulfan starting on day −10; and 200 mg/kg cyclophosphamide, 10 mg/kg thiotepa, and 12.5 mg/kg antithymocyte globulin daily from day −5 to −2. Fourteen patients received CD34+-mobilized peripheral blood and bone marrow progenitor cells; 8 patients received marrow graft–selected peripheral blood stem cells CD34+ and bone marrow CD3/CD19-depleted cells. T-cell dose was adjusted to 2 × 105/kg by fresh marrow cell addback at the time of transplantation. Both groups received cyclosporine for graft-versus-host disease prophylaxis for 2 months after transplantation. Two patients died (cerebral Epstein-Barr virus lymphoma or cytomegalovirus pneumonia), 6 patients reject their grafts, and 14 showed full chimerism with functioning grafts at a median follow-up of 40 months. None of the 14 patients who showed full chimerism developed acute or chronic graft-versus-host disease. These results suggest that maternal haploidentical hematopoietic stem cell transplantation is feasible in patients with thalassemia who lack a matched related donor.

17 June 2011 in Pediatric Reports
Verified
Journal Article
Open access
PDF file
PSPietro Sodani
Pietro Sodani
AIAntonella Isgrò
Antonella Isgrò
JGJavid Gaziev
Javid Gaziev
KPKatia Paciaroni
Katia Paciaroni
MMMarco Marziali
Marco Marziali
GLGuido Lucarelli
Guido Lucarelli
The cure for thalassemia involves correcting the genetic defect in a hematopoietic stem cell that results in reduced or absent β-globin synthesis and an excess of α-globin dimers.

1 February 2012 in Pathology - Research and Practice
Verified
Journal Article
Closed access
NDNicola Daniele
Nicola Daniele
MSMaria Cristina Scerpa
Maria Cristina Scerpa
MCMaurizio Caniglia
Maurizio Caniglia
MBMaria Ester Bernardo
Maria Ester Bernardo
CRCecilia Rossi
Cecilia Rossi
FZFrancesco Zinno
Francesco Zinno

20 October 1999 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
PDF file
Adriano VendittiAdriano Venditti
Adriano Venditti
ABAlessandra Battaglia
Alessandra Battaglia
GPGiovanni Del Poeta
Giovanni Del Poeta
Francesco BuccisanoFrancesco Buccisano
Francesco Buccisano
LML Maurillo
L Maurillo
SAS Amadori
S Amadori

20 May 2011 in Transfusion
Verified
Journal Article
Closed access
PDF file
FZFrancesco Zinno
Francesco Zinno
FLFabiola Landi
Fabiola Landi
MSMaria Cristina Scerpa
Maria Cristina Scerpa
VAViviana Aureli
Viviana Aureli
ALAlessandro Lanti
Alessandro Lanti
GIGiancarlo Isacchi
Giancarlo Isacchi

13 May 2006 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
FVFrancesco Velardi
Francesco Velardi
PAPaolina R. Amante
Paolina R. Amante
MCMaurizio Caniglia
Maurizio Caniglia
GRGiulio De Rossi
Giulio De Rossi
PGPierPaolo Gaglini
PierPaolo Gaglini
FZFrancesco Zinno
Francesco Zinno